Nearly 60 percent of drug candidates that enter Phase II clinical trials never advance to Phase … Why Phase II Clinical Trials Are the Graveyard of Drug DevelopmentRead more
What Happens When Pharma Ignores Real-World Evidence
In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more
How Pharma Marketing Impacts Clinical Trial Success
In the United States, nearly 80 percent of clinical trials fail to meet their original enrollment … How Pharma Marketing Impacts Clinical Trial SuccessRead more
Pharma Marketing Analytics Dashboards: Data-Driven Strategy in a Regulated Industry
Pharmaceutical marketing sits at the intersection of complex science, fast-moving market dynamics, and stringent regulatory oversight. … Pharma Marketing Analytics Dashboards: Data-Driven Strategy in a Regulated IndustryRead more
Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement
Pharmaceutical marketers face a dual mandate: deliver clinically relevant information while meeting strict regulatory obligations. Email … Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP EngagementRead more
Pharmaceutical Partnership Marketing
Pharmaceutical companies increasingly rely on partnership marketing to expand market reach, accelerate innovation, and improve patient … Pharmaceutical Partnership MarketingRead more
Interactive Quizzes for Patient Awareness in Pharmaceutical Marketing
The Emergence of Interactive Patient Education in Pharma Marketing Pharmaceutical marketing stands at a critical transformation … Interactive Quizzes for Patient Awareness in Pharmaceutical MarketingRead more
Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today
Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more
Common Clinical Trial Mistakes Pharma Companies Keep Repeating
Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more